Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$16,311,556
+$15,386,137 QoQ
Shares Held
64,821
+1423.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#700
of 4,153 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$257
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diversify Advisory Services, LLC holds $87,794,871 across 13 Drug Manufacturers - General names. ABBV ranks #3 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
94,734 | $24,059,593 | |
| 2 | LLY |
ELI LILLY & Co
|
16,684 | $20,011,291 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
64,821 | $16,311,556 | |
| 4 | AMGN |
Amgen Inc
|
22,302 | $8,076,000 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,135 | $3,743,847 | |
| 6 | NVS |
Novartis AG
|
20,054 | $3,142,862 | |
| 7 | PFE |
Pfizer Inc
|
117,466 | $2,828,581 | |
| 8 | GSK |
GSK plc
|
43,867 | $2,299,508 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,311,556 | 64,821 | Shares | Sole | 2026-08-10 | |
| 2026-06-30 | $257 | 100 | Call | Sole | 2026-08-10 | |
| 2026-03-31 | $925,419 | 4,255 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,952,036 | 30,426 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $7,137,452 | 30,826 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,712,641 | 30,776 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,167,981 | 19,893 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $3,217,258 | 18,105 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $4,853,465 | 24,577 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $4,937,889 | 28,789 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $6,260,598 | 34,380 | Shares | Sole | 2024-04-30 | |
| No filing history on record for this holder in this stock. | ||||||